These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24176953)

  • 1. Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: a meta-analysis.
    Yang D; Liu C; Shi J; Wang N; Du X; Yin Q; Wang Y
    Gene; 2014 Jan; 534(1):17-23. PubMed ID: 24176953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis demonstrates no association between XRCC1 Arg399Gln polymorphism and bladder cancer risk.
    Dong LM; Zhang XY; Teng H; Li MS; Wang P
    Genet Mol Res; 2014 Nov; 13(4):9976-85. PubMed ID: 25501209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
    Zhuo W; Zhang L; Cai L; Zhu B; Chen Z
    Exp Biol Med (Maywood); 2013 Jan; 238(1):66-76. PubMed ID: 23479765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.
    Chen Y; Li T; Li J; Mo Z
    Int J Biol Markers; 2015 Feb; 30(1):e12-21. PubMed ID: 25262700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the XRCC1 Arg399Gln polymorphism and head and neck cancer susceptibility: a meta-analysis based on case-control studies.
    Liu C; Yin Q; Jiao G; Zhou X; Ying M; Gao W; Hu J; Wei L; Wang N; Wang Y
    DNA Cell Biol; 2014 Jun; 33(6):378-87. PubMed ID: 24694255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of an association between the XRCC1 Arg399Gln polymorphism and gastric cancer based on a meta-analysis.
    Liu BM; Liu TM; You BS; You HY; Yang J; Li L; He YC
    Genet Mol Res; 2012 Nov; 11(4):3852-60. PubMed ID: 23212324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
    Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
    Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
    Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M; Ansari-Lari M
    Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of XRCC1 Arg399Gln and Arg194Trp polymorphisms with susceptibility to multiple autoimmune diseases: a meta-analysis.
    Peng M; Zhou X; Ding X; Wei L; Zhao Y; Zhu T; Shi X; Qin D
    Rheumatol Int; 2017 Mar; 37(3):435-444. PubMed ID: 27812739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the association between XRCC1 Arg399Gln and Arg194Trp polymorphisms and risk of cutaneous melanoma.
    Jiang H; Xu W; Zhang F; Wei L; Wang Y; Wang Y; Liu C
    Melanoma Res; 2016 Jun; 26(3):290-9. PubMed ID: 26967970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between X-ray repair cross-complementing group 1(XRCC1) Arg399Gln polymorphism and endometriosis: A systematic review and meta-analysis.
    Lv MQ; Wang J; Yu XQ; Hong HH; Ren WJ; Ge P; Zhou DX
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():12-20. PubMed ID: 28926725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis.
    Wang C; Sun Y; Han R
    Urology; 2008 Oct; 72(4):869-72. PubMed ID: 18336890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.
    Huang Y; Li L; Yu L
    Mutagenesis; 2009 Jul; 24(4):331-9. PubMed ID: 19465687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.
    Li D; Liu H; Yan L; Tang Y; Ren J; Xu Z
    Urol Int; 2012; 88(1):88-94. PubMed ID: 22156293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
    Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
    Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
    Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
    Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.